Evidence-based dentistry is a critical evaluation, awareness of the available evidence to improve decision making about the care of individual patients and / or communities. Objective: To systematically analyze the available scientific literature on clinical and radiographic results of two materials used in pulpotomy in primary teeth: formocresol and mineral trioxide aggregate. Materials and methods: It was identified relevant publications through a search of electronic databases such as MEDLINE (Ovid) and The Cochrane Library. To be included in the review, studies had to define the material used in child patients with pulp exposure by caries or tooth-alveolar trauma. Results: Of the 21 articles obtained in the initial phase of the review, only 19 were available in full text and of these only met the requirements for inclusion 6 items, which were confronted, analyzed and discussed later. Conclusions: The clinical evidence available showed significant differences regarding the use of a material or another. In addition to the findings of clinical follow -radiographic and taking into account the potential toxicity of formocresol suggest the use of mineral trioxide aggregate pulpotomy of primary teeth.
Introduction
The progress in understanding of molecular and cellular changes during dental development and how are they imitated during tissue repair, offers the opportunity of evaluating the biological validity of different strategies in vital pulp therapy. Under this perspective, and based on a good clinical history to arrive at a proper diagnosis, different pulp therapy options, such as indirect pulp treatment (IPT), direct pulp treatment (DPT), pulpotomy and pulpectomy are available (1) .
If a tooth with a carious lesion remains untreated or, is inadequately treated, a bacterial invasion of the coronal pulp will occur originating an inflammatory response at that level. In this stage the inflammation is confined to this space, but if the affected tissue is removed and the entrance to the root canals is covered with an appropriate agent, the remaining tissue is capable of recovering. This capability is used when a molar with a pulp exposure is treated with vital pulp therapy. In this manner, the main objective of pulp treatment is to preserve the e943 integrity and health of oral tissues. However, if a tooth can continue functioning without vital coronal pulp; it is desirable to preserve pulp vitality; therefore, the objective of vital pulpotomy is to treat reversible injury (2) . Pulpotomy is one the most frequently used treatments to maintain primary molars with carious involvement, symptomless or with reversible pulpitis which otherwise would be extracted. Its objective is to preserve radicular pulp, avoid pain, inflammation and, maintain the tooth (3) . Formocresol (FC) was first used in 1930 by Sweet who reported a success rate of 97%. It produces an area of necrosis adjacent to the lesion. The tissue is often altered by formaldehyde and appears "fixed" in situ and therefore is not subjected to liquefaction necrosis in the root canal. It is the most frequently used pulp capping agent in deciduous molars, however, formaldehyde which is the most important component of formocresol, shows certain risk of systemic distribution after its use (4). Several concerns have been expressed recently with respect to the use of formocresol in pulpotomies because of the following: pulp response with inflammation and necrosis, citotoxicity, systemic disturbances, possible mutagenicity and carcinogenicity and altered immune response. However with the advance of technology, different compounds are being studied in order to find one that provides better clinical efficacy without secondary effects, among them, the following have been widely reported in the scientific literature: electro surgery, Er:YAG laser, calcium hydroxide, glutaraldehide, ferric sulfate, collagen enriched solution, bone morphogenetic proteins or mineral trioxide aggregate (M.T.A.) (3). The objective of this systematic review of the literature is to compare the available evidence on the clinical and radiographic effects of formocresol with mineral trioxide aggregate in deciduous molars treated with pulpotomy.
Materials and Methods
A computarized search of the literature was done using MEDLINE (Ovid: 1960 (Ovid: -2008 (Table 1) , and The Cochrane Library. Randomized controlled trials which compared formocresol and/or mineral trioxide aggregate pulpotomies in primary teeth, were selected. The titles and abstracts of the studies were evaluated according to relevance after obtaining the full text articles. The search ended in January 2009. The inclusion criteria were: studies that evaluated pulp treatment of primary molars with vital pulp exposure due to caries or trauma which included drugs such as formocresol and/or mineral trioxide aggregate, follow up time of at least 6 months, symptomless teeth without indication of irreversible pulpitis, restorable teeth, and evaluation by clinical and radiographic methods. Exclusion criteria: lack of randomization of the subjects, animal or in vitro studies, absence of comparison between the treatment groups, the article could not be found. Initially we found 21 articles for possible inclusion, when the criteria were applied, 6 articles (randomized controlled clinical trials) were selected for further analysis (Table 2) . Afterwards, the articles were indexed in a digital data base and each one was evaluated taking as reference data, the authors, title, journal, year, volume, number, month and, pages. The methodology used was detailed and emphasis was also placed on the results (number of teeth, success rate, failure rate, frequencies). The results were confronted and analyzed to be discussed later.
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Results and Discussion
Formocresol was first introduced in 1904 (5) by Buckley; since then it is considered as the "gold standard" with which other drugs must be compared in pulpotomy experiments in primary molars. It became the most widely used drug due to its bacteriostatic and fixative properties, with a success rate varying from 55% to 98%. However, other authors suggest that the clinical and radiographic efficacy of formocresol varies between 70 to 97% (6) . Its chemical composition of formaldehyde (mutagenic and carcinogenic) and cresol (caustic agent), elicits concerns, even though there is no evidence that its systemic distribution can cause disease (7) . The histological response of the pulp after formocresol treatment seems to be unfavorable. Several researchers have reported that after application of formocresol, there is fixation of the coronal third in the radicular pulp and chronic inflammation in the middle third, leaving the apical third unaltered or vital. Other authors report that the remaining pulp tissue is partially or totally necrotic. Frequently, the pulp remains half vital, half necrotic and chronically inflamed. Although many studies published in the 90's questioned the safety and efficacy of formocresol, different researchers agree that it is potentially mutagenic but still is the drug of choice for pulpotomies in the deciduous dentition. (13) , in a randomized controlled study, selected 72 molars in 24 children for clinical and radiographic study. The selected teeth were randomly assigned and divided in to three groups according to the pulp filling material used (Gray MTA, White MTA or formocresol). An additional group of 15 teeth was prepared for serial extraction in order to carry out histological evaluation. The pulpotomies were performed by the same operator and the results evaluated by two pediatric dentists who did not know which tooth had which material was being evaluated (blind study).
The results showed that all 60 teeth were considered clinically and radiographically successfully at the first month of postoperative evaluation. At three months, a tooth from the white M.T.A. group was diagnosed as a clinical and radiographic failure due to an abscess, and was extracted. The 59 remaining teeth were considered as clinically and radiographically successful at the 3 month postoperative evaluation. At 6 months, a tooth from the Gray M.T.A. groups was lost due to exfoliation and the remaining 58 teeth were diagnosed as clinically and radiographically successful. At the 12 month evaluation, the 19 teeth from the Gray M.T.A. group were all considered clinically and radiographically successful. In the White M.T.A. group, 3 teeth were diagnosed as clinical and radiographic failures. The 16 remaining teeth in the Gray M.T.A. group were evaluated as clinical and radiographic success. Two teeth in the formocresol group were diagnosed as clinical and radiographic failures. When statistical tests were applied, there were no statistical significant differences between one material and the other. Farsi et al in 2005 (14) in a randomized controlled trial, compared the clinical and radiographic results of primary molars treated formocresol pulpotomy or MTA pulpotomy; they selected a randomized sample of 100 children for the study. A total of 120 teeth were included and the coronal pulp was amputated using a conventional pulpotomy technique. All the groups were treated under the same protocol, except for the application of the material. The teeth were divided in two equal groups, one group received MTA as filling material and FC was used in the other group. Their results showed that of the 120 treated teeth, only 74 were available for clinical and radiographic evaluation through the follow up period (24 months (15) in a comparative study of formocresol versus MTA pulpotomies, selected a total of 64 primary molars which received pulpotomies from a sample of 35 children randomly assigned by the toss of a coin to either one of the two groups. In case one of the children had two molars needing pulpotomies, the other molar was assigned to the alternative group. If a child needed 3 pulpotomies, the capping material was again decided by the toss of a coin. The children came back for re evaluation every 6 months for a total average of 38 months. Their results revealed that of the 64 molars treated, 62 teeth in 33 children were available for evaluation of success/failure rate. Two molars in two patients, both from the FC group were excluded from the study because the patients never returned for the follow up visits. The capping material used was MTA in 33 molars and FC in 29 molars. The failures were detected in 6 teeth after an average follow up period of 16 months. Twenty nine teeth with successful treatment were followed until their normal exfoliation with an average follow up period of 33 months. The remaining 27 successfully treated teeth had an average follow up period of 49 months with no difference between the experimental and the control group. The success rate of pulpotomies in all the teeth for this study was 90%. MTA was successful in 97% (32/33) and FC was successful in 83% (24/29) without statistical significant difference between the two materials. The follow up evaluation revealed 6 failures (10%): 5 of them in the FC group and 1 in the MTA group. The most common radiographic finding among all teeth was obliteration of the root canals 55% (34/62). It was found in 58% of the MTA treated teeth (19/33) and in 52% (15/29) of the FC treated teeth, followed by internal resorption which was observed in 8 teeth (6 with FC and 2 with MTA). The least frequent finding was a dentinal bridge which was detected on tooth treated with MTA. Naik and Hedge in 2005 (16) in a randomized controlled trial included 50 symptomless primary molars with deep carious lesions and randomly assigned for treatment with FC or with MTA (25 teeth per group). All teeth were restored with stainless steel crowns and clinical and radiographic controls were done during 6 months (Controls at 1-3-6 months).
The results revealed that of the 50 teeth selected, 3 were not available for follow up after the first month. The follow up appointments after the first, third and sixth months did not show any clinical or radiographic pathological findings on the rest of the 47 teeth, therefore, no statistical analysis was carried out due to the success of the treatment. The only significant finding was color change in 60% of the teeth in which MTA was the medicament used after 24 hours, but was later masked when the stainless steel crown was placed. 
Conclusions
The present available literature is an important tool for rationalizing correct clinical decisions. This is why the scientific efforts to improve do not stop and include new concepts and treatment strategies in order to reduce the incidence of adverse effects and increase their biocompatibility. Based on the scientific evidence found until now, human primary molars with reversible pulpitis, with pulp exposure due to caries or to dentoalveolar trauma, can be treated with formocresol or mineral trioxide aggregate, with similar success rates but with significant differences as is evidenced by a recent meta-analysis. Considering the frequency of appearance of radiographic findings, such as furcation involvement, and its questionable citotoxicity, as it regards to the use of formocresol, the authors suggest the application of mineral trioxide aggregate.
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